ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Exelon 2 mg/ml, Lösung zum Einnehmen - 120 ml
55051002 Novartis Pharma Schweiz AG
Exelon 2 mg/ml, Lösung zum Einnehmen04.06.1999
  04.06.1999
Rivastigmine (N06DA03)26.01.2006
WHO-DDD 
01.99.120 ml
01.99. 
B  
Yes 
IPCI
68.98Yes
    
10 %95.70
7680550510025Synthetika
2155505 
Composition
rivastigminum 2 mg ut rivastigmini hydrogenotartras, acidum citricum, natrii citras dihydricus, E 104, E 211 1 mg, aqua purificata, ad solutionem pro 1 ml corresp. natrium 1.82 mg.
Packungsbestandteile
Solution (oral) 
  
 
Active AgentDose
Rivastigmine2 mg/ml
BAG: Active AgentDose
Rivastigmine2 mg
 
Inactive agentsDoseadditional_information
Citric Acid  
Aqua Purificata  
E 104 color.
E 2111 mg/mlconserv.
Natrii Citras Dihydricus  
 
Source
Data was imported : 06.02.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home